Macro Biologics creates synthetic biological polymers for therapeutic and biotechnology applications.
Macro Biologics has raised $5.0M in total funding. The most recent round was Grant. The last funding was announced in December 2025.
Macro Biologics's investors include CARB-X.
Macro Biologics is headquartered in Carlsbad, United States.
Macro Biologics creates synthetic biological polymers for therapeutic and biotechnology applications.
Macro Biologics is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Macro Biologics — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/macro-biologics. Accessed November 13, 2026.
VCBacked. (2025). Macro Biologics — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/macro-biologics
{{cite web |title=Macro Biologics — Funding & Investors |url=https://www.vcbacked.co/company/macro-biologics |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Macro Biologics? Request a listing update